Corcept Therapeutics's total assets for Q2 2025 were $801.72M, a decrease of -5.28% from the previous quarter. CORT total liabilities were $165.93M for the fiscal quarter, a 1.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.